Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease

Journal of Clinical Neuroscience

Volumn 14, Issue 9, 2007, Pages 850-855

  Ito, T ^a   Meguro, K ^a,b   Akanuma, K ^b   Meguro, M ^b   Lee, E ^a,b,c   Kasuya, M ^a,d   Ishii, H ^a,e   Mori, E ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaki Tajiri SKIP Center   (Japan)

^c Woosong University   (South Korea)

^d MIYAGI UNIVERSITY   (Japan)

^e Kawasaki Kokoro Hospital   (Japan)

Author keywords

Alzheimer's disease; BPSD; Cognitive function; Risperidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; RISPERIDONE;

AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR CHANGE; BEHAVIORAL PATHOLOGY IN ALZHEIMER DISEASE FREQUENCY WEIGHTED SEVERITY SCALE; CLINICAL ARTICLE; COGNITION; COGNITIVE ABILITIES SCREENING INSTRUMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHIATRIC SYMPTOM INDEX; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; THERAPY EFFECT; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; BEHAVIORAL SYMPTOMS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; RISPERIDONE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34547095549     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2006.06.010     Document Type: Article

References (27)

1. Meguro K., Ueda M., Yamaguchi T., et al. Disturbance in daily sleep/wake patterns in patients with cognitive impairment and decreased daily activity. J Am Geriatr Soc 38 (1990) 1176-1182
2. Meguro K., Ueda M., Kobayashi I., et al. Sleep disturbance in elderly patients with cognitive impairment, decreased daily activity and periventricular white matter lesions. Sleep 18 (1995) 109-114
3. Meguro K., Yamaguchi S., Yamazaki H., et al. Cortical glucose metabolism in psychiatric wandering patients with vascular dementia. Psychiatr Res 67 (1996) 71-80
4. Finkel S.I., Costa e Silva J., Cohen G., et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 8 S3 (1996) 497-500
5. Tery L. Behavior and caregiver burden: behavioral problems in patients with Alzheimer disease and its association with caregiver distress. Alzheimer Dis Assoc Disord 4 (1997) 35-38
6. Reisberg B. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatr 48 S5 (1987) 9-15
7. Monteiro I.M., Boksay I., Auer S.R., et al. Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability. Eur Psychiatr 16 S1 (2001) 5-24
8. Braak H., and Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Ber) 82 (1991) 239-259
9. McKhann G., Drachman D., Folstein M., et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
10. Cummings J., Mega M., Gray K., et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 12 (1994) 2308-2314
11. Asada T., Honma A., Kimura M., et al. The reliability of Japanese version of BEHAVE-AD scale. Jap J Geriatr Psychiatr 10 (1999) 825-834
12. Teng E.L., Hasegawa K., Homma A., et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6 (1993) 45-57
13. Folstein F.M., Folstein S.E., and McHugh P.R. "Mini-mental State" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
14. Ishizaki J., Meguro K., Ishii H., et al. The effects of group work therapy in patients with Alzheimer's disease. Int J Geriatr Psychiatry 15 (2000) 532-535
15. De Deyn P.P., Rabheru K., Rasmusses A., et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53 (1999) 946-955
16. Shigenobu K., Ikeda M., Fukuhara R., et al. Reducing the burden of caring for Alzheimer's disease through the amelioration of "delusion of theft" by drug therapy. Int J Geriatr Psychiatry 17 (2002) 211-217
17. Meguro K., Meguro M., Tanaka Y., et al. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease. J Geriatr Psychiatry 17 (2004) 61-67
18. Aalten P., de Vugt M.E., Lousberg R., et al. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord 15 (2003) 99-105
19. Lyketsos C.G., Sheppard J.M.E., Steinberg M., et al. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache Country study. Int J Geriatr Psychiatry 16 (2001) 1043-1053
20. Spalletta G., Baldinetti F., Buccione I., et al. Cognition and behavior are independent and heterogeneous dimensions in Alzheimer's disease. J Neurol 251 (2004) 688-695
21. Schneider L.S., Katz I.R., Park S., et al. Psychosis of Alzheimer's disease: validity of the construct and response to risperidone. Am J Geriatr Psychiatry 11 (2003) 414-425
22. Brodaty H., Ames D., Snowdon J., et al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 64 (2003) 134-143
23. Rabinowitz J., Katz I.R., De Deyn P.P., et al. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone. J Clin Psychiatry 65 (2004) 1329-1334
24. Suh G.H., Son H.G., Ju Y.S., et al. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances. Am J Geriatr Psychiatry 12 (2004) 509-516
25. Kapur S., and Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153 (1996) 466-476
26. Meguro K., Yamaguchi S., Shimada M., et al. Striatal dopaminergic transmission and neocortical glucose utilization in Alzheimer's disease: a triple-tracer positron emission tomography study. Arch Gerontol Geriatr 31 (2000) 147-158
27. Cummings J.L., Donobue J.A., and Brooks R.L. The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease. J Geriatr Psychiatry 8 (2000) 134-140